Nova received the first dose of the Covid vaccine during a visit to a private medical college hospital in Kochi on July 28.
Yogita K. Adlakha, developed the models to study neuron development and neuro-developmental disorders such as autism which can help design treatment strategies.
The study, published in the journal Brain Communications, looked into 267 cases of COVID-19 related neurological and psychiatric problems in the UK.
Dr Gagandeep Singh, a member of the team that conducted the study says that lifestyle diseases are more prevalent in Kerala.
Dopamine is a neurotransmitter that is released in the brain. It can contribute to a feeling of satisfaction and is linked to learning, attention and the ability to focus.
The work opens the door to establish the significance of ICAM-1 as a novel therapeutic target against the pathophysiology thereby improve functional recovery after traumatic brain injury.
The study showed that a severe inflammatory response can develop in the central nervous system of COVID-19 patients.
On the occasion of World Brain Tumour Day, health experts recommend all such to opt for COVID-19 vaccination at the earliest, because of the vulnerabilities.
Tumours classified as grade II can progress to become cancerous and more aggressive treatment may be needed in order to try to control their spread.
The gene, among other things, affects the function of a protein that helps the brain's blood vessels to react correctly to damage, such as a low oxygen supply to the brain.